📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Metabolomic consequences of genetic inhibition of PCSK9 compared with statin treatment (2018)

First Author: Eeva Sliz

Attributed to: Glasgow Molecular Pathology (GMP) Node funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.60692/9tsbd-60n59

Publication URI: https://gresis.osc.int//doi/10.60692/9tsbd-60n59

Type: Other